Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Halfvarson

Showing results (101-110 of 244) with videos related to

Pageof 25
Sort By:
Alimentary Pharmacology & Therapeutics|September 9, 2020
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in SwedenHamed Khalili, Åsa H Everhov, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|March 17, 2021
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel DiseaseJoana Torres, Jonas Halfvarson, Iago Rodríguez-Lago, et al.
Digestive Diseases and Sciences|March 17, 2023
Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's DiseaseCarl Eriksson, Jonas Söderling, Sara Karlqvist, et al.
Journal of Clinical Medicine|March 17, 2025
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel DiseaseGionata Fiorino, Ashwin Ananthakrishnan, Russell D Cohen, et al.
Inflammatory Bowel Diseases|July 8, 2020
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's DiseaseWalter Reinisch, Krisztina Gecse, Jonas Halfvarson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2021
Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort StudyRune Erichsen, Ola Olén, Michael C Sachs, et al.
Scandinavian Journal of Gastroenterology|January 3, 2019
Validating microscopic colitis (MC) in Swedish pathology registersMagnus Svensson, David Bergman, Ola Olén, et al.
Journal of Crohn'S & Colitis|March 22, 2024
Spondyloarthritis in First-Degree Relatives and Spouses of Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study from SwedenSarita Shrestha, Judith S Brand, Mehdi Osooli, et al.
Inflammatory Bowel Diseases|July 1, 2022
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort StudyJohanna Holmgren, Anna Fröborg, Isabella Visuri, et al.
Lancet (London, England)|January 14, 2020
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort studyOla Olén, Rune Erichsen, Michael C Sachs, et al.
Pageof 25

Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
Alimentary Pharmacology & Therapeutics|September 9, 2020
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in SwedenHamed Khalili, Åsa H Everhov, Jonas Halfvarson, et al.
Journal of Crohn'S & Colitis|March 17, 2021
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel DiseaseJoana Torres, Jonas Halfvarson, Iago Rodríguez-Lago, et al.
Digestive Diseases and Sciences|March 17, 2023
Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's DiseaseCarl Eriksson, Jonas Söderling, Sara Karlqvist, et al.
Journal of Clinical Medicine|March 17, 2025
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel DiseaseGionata Fiorino, Ashwin Ananthakrishnan, Russell D Cohen, et al.
Inflammatory Bowel Diseases|July 8, 2020
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's DiseaseWalter Reinisch, Krisztina Gecse, Jonas Halfvarson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2021
Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort StudyRune Erichsen, Ola Olén, Michael C Sachs, et al.
Scandinavian Journal of Gastroenterology|January 3, 2019
Validating microscopic colitis (MC) in Swedish pathology registersMagnus Svensson, David Bergman, Ola Olén, et al.
Journal of Crohn'S & Colitis|March 22, 2024
Spondyloarthritis in First-Degree Relatives and Spouses of Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study from SwedenSarita Shrestha, Judith S Brand, Mehdi Osooli, et al.
Inflammatory Bowel Diseases|July 1, 2022
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort StudyJohanna Holmgren, Anna Fröborg, Isabella Visuri, et al.
Lancet (London, England)|January 14, 2020
Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort studyOla Olén, Rune Erichsen, Michael C Sachs, et al.
Pageof 25